Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Bone Marrow-Derived Stem Cell Transplantation for Retinitis Pigmentosa
NCT02709876Phase 2Unknown
- Sponsor
- Stem Cells Arabia
- Start
- Apr 2014
- Primary completion
- Sep 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived CD34+ CD133+ CD271+ stem cells in retinitis pigmentosa (RP), sponsored by Stem Cells Arabia. Status: unknown.
02
Drugs
autologous bone marrow-derived CD34+ CD133+ CD271+ stem cells
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT02709876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02709876.